Trademarkia Logo

Canada

C$
CYCLERION DESIGN
REGISTERED

on 20 Oct 2023

Last Applicant/ Owned by

CYCLERION THERAPEUTICS INC.

301 Binney StreetCambridge, MA 02142

US

Serial Number

1963858 filed on 21st May 2019

Registration Number

TMA1204560 registered on 20th Oct 2023

Registration expiry Date

20th Oct 2033

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

CYCLERION DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal sy Read More

Vienna Information


1 . 3 . 15

Sun with rays constituted by rectilinear lines, sheaves of lines or bandsSoleil à rayons constitués par des traits, des faisceaux de traits ou des bandes rectilignes

1 . 3 . 17

Sun with rays constituted by trianglesSoleil à rayons constitués par des triangles

1 . 3 . 2

Other representations of the sunAutres représentations du soleil

25 . 12 . 1

Surfaces or backgrounds covered with rays or radiating linesSurfaces ou fonds rayonnés

26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 5

Triangles pointing downwardsTriangles avec la pointe en bas

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 18

Circles or ellipses containing one or more lettersCercles ou ellipses contenant une ou plusieurs lettres

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

26 . 7 . 3

Circles or ellipses with one or more triangles and/or lines forming an angleCercles ou ellipses avec un ou plusieurs triangles et/ou lignes formant un angle

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 12

Letters or numerals representing a heavenly body or a natural phenomenonLettres ou chiffres représentant un corps céleste ou un phénomène naturel

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds, namely, pharmaceutical preparations and substances that stimulate guanylate cyclases (sGC), increase the concentration of nitric oxide (NO), increase the concentration of cyclic guanosine monophosphate (cGMP), upregulate the NO-sGC-cGMP (nitric oxide- soluble guanylate cyclases- cyclic guanosine monophosphate) pathway; pharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds, namely, pharmaceutical preparations and substances that utilize a synergistic interaction of the NO-sGC-cGMP (nitric oxide- soluble guanylate cyclases- cyclic guanosine monophosphate) pathway with a complementary signaling pathway; pharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds


Classification kind code

12

Class [042]
Pharmaceutical research and development; conducting pharmaceutical clinical trials; pharmaceutical product development


Classification kind code

12

Mark Details


Serial Number

1963858

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 27th Sept 2023
Registration Pending
Submitted for opposition 42
on 5th Jul 2023
Advertised
Submitted for opposition 26
on 8th Jun 2023
Approved
Submitted for opposition 27
on 8th Jun 2023
Approval Notice Sent
Submitted for opposition 22
on 28th Oct 2022
Search Recorded
Submitted for opposition 20
on 28th Oct 2022
Examiner's First Report
Submitted for opposition 287
on 28th Mar 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 27th May 2019
Formalized
Submitted for opposition 30
on 21st May 2019
Filed
Submitted for opposition 1
on 21st May 2019
Created